Circulating Biomarker Validation
Circulating Biomarker Validation is a translational biomarker validation approach that specifically involves the verification and analytical qualification of molecular indicators in biofluids to ensure their accuracy, reproducibility, and clinical relevance for disease detection or monitoring.
32
Publications
1.3K
Citations
275
Authors
114
Institutions
Publications per year
2017–2026
21
32
MiRNA‐199a‐3p: A potential circulating diagnostic biomarker for early gastric cancer
Chen Li, Jian Fang Li, Qu Cai et al. · Journal of Surgical Oncology · 2013 · 83 citations
Circulating miR-1290 and miR-320d as Novel Diagnostic Biomarkers of Human Colorectal Cancer
Xiangxiang Liu, Xueni Xu, Bei Pan et al. · Journal of Cancer · 2018 · 66 citations · Full text
1–5 of 32
275
Johannes Gutenberg University Mainz, Germany
1 publications · 38 citations
1
h-index
1
h-index
The University of Texas Southwestern Medical Center, United States
1 publications · 43 citations
1
h-index
1
h-index
The University of Texas Southwestern Medical Center, United States
1 publications · 43 citations
1
h-index
1–5 of 275
114
Inserm
Paris, France
3 h-index
22 publications
457 citations
Heidelberg University
Heidelberg, Germany
3 h-index
15 publications
483 citations

Shanghai Jiao Tong University
Shanghai, China
3 h-index
33 publications
1.4K citations

Ruijin Hospital
Shanghai, China
2 h-index
27 publications
1.2K citations

Centre National de la Recherche Scientifique
Paris, France
2 h-index
7 publications
263 citations

Institut Pasteur de Lille
Lille, France
2 h-index
14 publications
361 citations
Université de Lille
Lille, France
2 h-index
14 publications
361 citations
German Cancer Research Center
Heidelberg, Germany
2 h-index
12 publications
391 citations
1–8 of 114
3 publications · 140 citations
3
h-index
2 publications · 49 citations
2
h-index
IJMS · 2 publications · 34 citations
2
h-index
JEV · 1 publications · 187 citations
1
h-index
1 publications · 23 citations
1
h-index
1–5